Pub Date : 2026-03-02eCollection Date: 2026-01-01DOI: 10.3389/fcimb.2026.1731341
Maisah Meyhr D'Carmo Sodré, Ian David Araújo Cruz, Uener Ribeiro Santos, Sheila Cristina Potente Dutra Luquetti, Vânia Lúcia Silva, Alessandra Barbosa Ferreira Machado, Cláudio Galuppo Diniz, Cláudio Teodoro de Souza, Carla Cristina Romano, Lauro Juliano Marin, Luciana Debortoli de Carvalho
Antimicrobial resistance (AMR) is a critical global health threat that may cause up to 10 million deaths annually by 2050, requiring integrated actions within the One Health framework. The misuse of antimicrobials across human, animal, and environmental sectors has intensified the spread of multidrug-resistant bacteria, including Escherichia coli, Staphylococcus aureus, and Klebsiella pneumoniae. In this context, Lactobacillus-derived postbiotics have emerged as eco-friendly alternatives with antimicrobial and antibiofilm properties. A systematic review was conducted to consolidate scientific evidence on the strategic potential of Lactobacillus cell-free supernatants, with a specific focus on Limosilactobacillus fermentum. Studies published between 2000 and July 2025 were screened, prioritizing investigations that evaluated antimicrobial activity, biofilm inhibition, and efficacy in biological and technological models against multidrug-resistant pathogens. After screening, 95 studies were included in the analysis. L. fermentum was deliberately selected as the focus species based on consistent evidence of postbiotic efficacy against pathogenic bacteria and biofilm formation. The reviewed studies also demonstrated favorable physicochemical stability of L. fermentum cell-free derivatives, supporting their safety and scalability for applied use. This review highlights L. fermentum as a strategic model within One Health aligned approaches to combat AMR. The findings reinforce the role of postbiotics as sustainable, effective, and scalable tools for mitigating antimicrobial resistance across human, animal, and environmental interfaces.
{"title":"Probiotic cell-free supernatants as a strategy against antimicrobial resistance: a systematic review.","authors":"Maisah Meyhr D'Carmo Sodré, Ian David Araújo Cruz, Uener Ribeiro Santos, Sheila Cristina Potente Dutra Luquetti, Vânia Lúcia Silva, Alessandra Barbosa Ferreira Machado, Cláudio Galuppo Diniz, Cláudio Teodoro de Souza, Carla Cristina Romano, Lauro Juliano Marin, Luciana Debortoli de Carvalho","doi":"10.3389/fcimb.2026.1731341","DOIUrl":"https://doi.org/10.3389/fcimb.2026.1731341","url":null,"abstract":"<p><p>Antimicrobial resistance (AMR) is a critical global health threat that may cause up to 10 million deaths annually by 2050, requiring integrated actions within the One Health framework. The misuse of antimicrobials across human, animal, and environmental sectors has intensified the spread of multidrug-resistant bacteria, including <i>Escherichia coli, Staphylococcus aureus</i>, and <i>Klebsiella pneumoniae</i>. In this context, <i>Lactobacillus</i>-derived postbiotics have emerged as eco-friendly alternatives with antimicrobial and antibiofilm properties. A systematic review was conducted to consolidate scientific evidence on the strategic potential of Lactobacillus cell-free supernatants, with a specific focus on <i>Limosilactobacillus fermentum</i>. Studies published between 2000 and July 2025 were screened, prioritizing investigations that evaluated antimicrobial activity, biofilm inhibition, and efficacy in biological and technological models against multidrug-resistant pathogens. After screening, 95 studies were included in the analysis. <i>L. fermentum</i> was deliberately selected as the focus species based on consistent evidence of postbiotic efficacy against pathogenic bacteria and biofilm formation. The reviewed studies also demonstrated favorable physicochemical stability of <i>L. fermentum</i> cell-free derivatives, supporting their safety and scalability for applied use. This review highlights <i>L. fermentum</i> as a strategic model within One Health aligned approaches to combat AMR. The findings reinforce the role of postbiotics as sustainable, effective, and scalable tools for mitigating antimicrobial resistance across human, animal, and environmental interfaces.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1731341"},"PeriodicalIF":4.8,"publicationDate":"2026-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12989548/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147472248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-27eCollection Date: 2026-01-01DOI: 10.3389/fcimb.2026.1749504
Shanshan Mei, Jingyi Ye, Yaoyao Teng, Yisheng Chen, Yan Long, Xueqin Zhao, Xueqing Cen, Xiaoyan Zhang, Chunyan Zhu
<p><strong>Background: </strong>Exposure to particulate matter pollution with aerodynamic diameters < 2.5 μm (PM<sub>2.5</sub>) has been linked to gestational diabetes mellitus (GDM) and gut microbiota dysbiosis. However, few studies have illustrated the associations among PM<sub>2.5</sub> exposure, gut microbiota, blood metabolites, circular RNAs (circRNAs) and GDM risk. This study aimed to explore the moderating effects of the gut microbiota on the association between PM<sub>2.5</sub> exposure and GDM, and to analyze the interaction network of PM<sub>2.5</sub> exposure, gut microbiota, blood metabolites and circRNAs.</p><p><strong>Methods: </strong>Participants (n = 1,248) were selected from the Pregnancy Metabolic Disease and Adverse Pregnancy Outcome (PMDAPO) cohort in Guangzhou, China. Demographic information, blood and fecal samples were collected from the participants. The fecal microbial composition and relative abundance were characterized using 16S rRNA gene sequencing, while blood differential metabolites and circRNAs of pregnant women with GDM were assessed using non-targeted metabolomics and RT-qPCR, respectively. Exposure levels of air pollutants were assessed using data from the nearest monitoring station. Spearman correlation and regression models were conducted to estimate the associations among PM<sub>2.5</sub> exposure, gut microbiota, blood metabolites, circRNAs and GDM.</p><p><strong>Results: </strong>Elevated PM<sub>2.5</sub> exposure levels were significantly associated with an increased risk of GDM, impaired glucose homeostasis and gut microbiota dysbiosis. <i>Solobacterium</i> and <i>Escherichia_Shigella</i> showed a positive effect modification on the association between PM<sub>2.5</sub> exposure and fasting blood glucose, while <i>Fusicatenibacter</i>, <i>Ruminococcaceae_UBA1819</i>, <i>Raoultibacter</i>, <i>Anaerofustis</i> and <i>Phascolarctobacterium</i> showed a negative effect modification on the association between PM<sub>2.5</sub> exposure and 2-h OGTT glucose. GDM-associated gut microbiota, including <i>Catabacter</i>, <i>Angelakisella</i>, <i>Romboutsia</i> and <i>Fusicatenibacter</i>, were associated with both GDM-associated metabolites (such as sphinganine-1-phosphate, sphingomyelin) and GDM-associated circRNAs (such as hsa_circ_0006732 and hsa_circ_0001439), which were involved in glycerophospholipid metabolism, sphingolipid metabolism and insulin signaling pathway.</p><p><strong>Conclusions: </strong>The gut microbiota may moderate the associations between PM<sub>2.5</sub> exposure and blood glucose levels, and both PM<sub>2.5</sub> exposure and gut microbiota may be related to GDM, potentially involving pathways such as glycerophospholipid metabolism, sphingolipid metabolism and the insulin signaling pathway. However, lifestyle factors (diet and physical activity) and residential mobility were not measured, and the fecal microbiota was assessed at a single time point in mid-pregnancy. Thus, these limitatio
背景:暴露于空气动力学直径< 2.5 μm (PM2.5)的颗粒物污染与妊娠糖尿病(GDM)和肠道菌群失调有关。然而,很少有研究表明PM2.5暴露、肠道微生物群、血液代谢物、环状rna (circRNAs)和GDM风险之间存在关联。本研究旨在探讨肠道菌群对PM2.5暴露与GDM相关性的调节作用,分析PM2.5暴露、肠道菌群、血液代谢物和环状rna之间的相互作用网络。方法:从中国广州妊娠代谢性疾病和不良妊娠结局(PMDAPO)队列中选择参与者(n = 1,248)。收集了参与者的人口统计信息、血液和粪便样本。采用16S rRNA基因测序对粪便微生物组成和相对丰度进行了表征,采用非靶向代谢组学和RT-qPCR对妊娠期GDM孕妇的血液差异代谢物和环状rna进行了评估。利用最近监测站的数据评估了空气污染物的暴露水平。采用Spearman相关和回归模型来估计PM2.5暴露、肠道微生物群、血液代谢物、环状rna和GDM之间的关系。结果:PM2.5暴露水平升高与GDM风险增加、葡萄糖稳态受损和肠道微生物群失调显著相关。Solobacterium和Escherichia_Shigella对PM2.5暴露与空腹血糖的关系表现出正作用,Fusicatenibacter、Ruminococcaceae_UBA1819、Raoultibacter、Anaerofustis和Phascolarctobacterium对PM2.5暴露与2 h OGTT血糖的关系表现出负作用。与gdm相关的肠道微生物群,包括Catabacter、Angelakisella、Romboutsia和Fusicatenibacter,与gdm相关的代谢物(如鞘氨胺-1-磷酸、鞘磷脂)和与gdm相关的环状rna(如hsa_circ_0006732和hsa_circ_0001439)相关,这些环状rna参与甘油磷脂代谢、鞘脂代谢和胰岛素信号通路。结论:肠道菌群可能调节PM2.5暴露与血糖水平之间的关系,PM2.5暴露和肠道菌群都可能与GDM有关,可能涉及甘油磷脂代谢、鞘脂代谢和胰岛素信号通路等途径。然而,没有测量生活方式因素(饮食和身体活动)和居住流动性,并且在怀孕中期的单个时间点评估粪便微生物群。因此,这些限制可能导致残留混淆、暴露错误分类和有限的因果推断。
{"title":"Longitudinal associations between PM<sub>2.5</sub> with gestational diabetes mellitus mediated by gut microbiome and potential mechanism: based on a prospective pregnant women cohort in China.","authors":"Shanshan Mei, Jingyi Ye, Yaoyao Teng, Yisheng Chen, Yan Long, Xueqin Zhao, Xueqing Cen, Xiaoyan Zhang, Chunyan Zhu","doi":"10.3389/fcimb.2026.1749504","DOIUrl":"10.3389/fcimb.2026.1749504","url":null,"abstract":"<p><strong>Background: </strong>Exposure to particulate matter pollution with aerodynamic diameters < 2.5 μm (PM<sub>2.5</sub>) has been linked to gestational diabetes mellitus (GDM) and gut microbiota dysbiosis. However, few studies have illustrated the associations among PM<sub>2.5</sub> exposure, gut microbiota, blood metabolites, circular RNAs (circRNAs) and GDM risk. This study aimed to explore the moderating effects of the gut microbiota on the association between PM<sub>2.5</sub> exposure and GDM, and to analyze the interaction network of PM<sub>2.5</sub> exposure, gut microbiota, blood metabolites and circRNAs.</p><p><strong>Methods: </strong>Participants (n = 1,248) were selected from the Pregnancy Metabolic Disease and Adverse Pregnancy Outcome (PMDAPO) cohort in Guangzhou, China. Demographic information, blood and fecal samples were collected from the participants. The fecal microbial composition and relative abundance were characterized using 16S rRNA gene sequencing, while blood differential metabolites and circRNAs of pregnant women with GDM were assessed using non-targeted metabolomics and RT-qPCR, respectively. Exposure levels of air pollutants were assessed using data from the nearest monitoring station. Spearman correlation and regression models were conducted to estimate the associations among PM<sub>2.5</sub> exposure, gut microbiota, blood metabolites, circRNAs and GDM.</p><p><strong>Results: </strong>Elevated PM<sub>2.5</sub> exposure levels were significantly associated with an increased risk of GDM, impaired glucose homeostasis and gut microbiota dysbiosis. <i>Solobacterium</i> and <i>Escherichia_Shigella</i> showed a positive effect modification on the association between PM<sub>2.5</sub> exposure and fasting blood glucose, while <i>Fusicatenibacter</i>, <i>Ruminococcaceae_UBA1819</i>, <i>Raoultibacter</i>, <i>Anaerofustis</i> and <i>Phascolarctobacterium</i> showed a negative effect modification on the association between PM<sub>2.5</sub> exposure and 2-h OGTT glucose. GDM-associated gut microbiota, including <i>Catabacter</i>, <i>Angelakisella</i>, <i>Romboutsia</i> and <i>Fusicatenibacter</i>, were associated with both GDM-associated metabolites (such as sphinganine-1-phosphate, sphingomyelin) and GDM-associated circRNAs (such as hsa_circ_0006732 and hsa_circ_0001439), which were involved in glycerophospholipid metabolism, sphingolipid metabolism and insulin signaling pathway.</p><p><strong>Conclusions: </strong>The gut microbiota may moderate the associations between PM<sub>2.5</sub> exposure and blood glucose levels, and both PM<sub>2.5</sub> exposure and gut microbiota may be related to GDM, potentially involving pathways such as glycerophospholipid metabolism, sphingolipid metabolism and the insulin signaling pathway. However, lifestyle factors (diet and physical activity) and residential mobility were not measured, and the fecal microbiota was assessed at a single time point in mid-pregnancy. Thus, these limitatio","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1749504"},"PeriodicalIF":4.8,"publicationDate":"2026-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12982432/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147462901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><strong>Purpose: </strong>Extensively drug-resistant <i>Pseudomonas aeruginosa</i> (XDR-PA) has posed a great threat to public health due to their rising incidence and complicated resistance mechanisms and limited treatment options. XDR-PA has demonstrated high resistance rate to new antibiotic ceftazidime-avibactam (CZA). Therefore, this study was conducted to describe the resistance mechanisms, molecular epidemiology, and type III secretion system (T3SS) of XDR-PA, as well as to evaluate the synergistic antibacterial activity of CZA combined with aztreonam (ATM) against XDR-PA via <i>in vitro</i> experiments, aiming at providing insights for the prevention, control and treatment strategies of XDR-PA infections.</p><p><strong>Methods: </strong>The carbapenemase resistance genes (VIM, IMP, NDM, KPC, GES, OXA-40) and T3SS virulence genes of XDR-PA isolates were identified using polymerase chain reaction (PCR) and sequencing. The expression levels of efflux pump systems (<i>mexA and mexC</i>), <i>oprD2</i> porin and <i>ampC</i> were detected by the real-time fluorescent quantitative PCR (qPCR). The homology analysis of XDR-PA isolates was performed using multilocus sequence typing (MLST). Combined antimicrobial susceptibility testing of CZA and ATM were performed for XDR-PA isolates through <i>in vitro</i> experiments.</p><p><strong>Results: </strong>A total of 32 XDR-PA strains were isolated from clinical specimens from a tertiary teaching hospital in Southwest China between October 2022 to October 2023. Among the carbapenemase detected, metallo-β-lactamase (MBL) NDM-1 and VIM-2 were detected in 26 strains (81.25%, 26/32) and 1 strain (3.13%, 1/32) respectively. The efflux pump <i>mexA</i> had a higher expression in the XDR-PA group than that in the sensitive-PA (S-PA) group (<i>P</i> = 0.015). The T3SS virulence genes carried by XDR-PA strains mainly were <i>exoY+/exoT+/exoU+/exoS-</i> (87.50%, 28/32). The 32 XDR-PA isolates belonged to 8 different ST types, mainly including ST1971 and ST308, and the predominant ST type was ST1971 (71.88%, 23/32), with carrying both NDM-1 and <i>exoY+/exoT+/exoU+/exoS-</i>. Combined antimicrobial susceptibility testing revealed that among the 27 CZA-resistant XDR-PA strains, CZA and ATM combination showed a synergistic effect on 21 CZA-resistant XDR-PA strains (77.78%, 21/27), of which 20 strains carrying both MBL (95.24%, 20/21) and <i>exoY+/exoT+/exoU+/exoS-</i>.</p><p><strong>Conclusion: </strong>The underlying resistance mechanisms of XDR-PA isolates involve the overexpression of efflux pump <i>mexA</i> and the existence of MBL. In addition, ST1971 was the predominant ST type in our study, with carrying both NDM-1 and <i>exoY+/exoT+/exoU+/exoS-</i>. Furthermore, combined antimicrobial susceptibility testing suggested that CZA and ATM combination has potential against MBL-producing <i>exoY+/exoT+/exoU+/exoS-</i> XDR-PA. These findings may provide clues for the prevention, control and treatment strategies of
{"title":"Synergistic activity of ceftazidime/avibactam combined with aztreonam against MBL-producing <i>exoY+/exoT+/exoU+/exoS-</i> extensively drug-resistant <i>Pseudomonas aeruginosa</i>.","authors":"Xianzhen Wei, Mingbo Liu, Runxian Tan, Peng Huang, Xia Fang, Shan Li, Meng Li","doi":"10.3389/fcimb.2026.1737414","DOIUrl":"10.3389/fcimb.2026.1737414","url":null,"abstract":"<p><strong>Purpose: </strong>Extensively drug-resistant <i>Pseudomonas aeruginosa</i> (XDR-PA) has posed a great threat to public health due to their rising incidence and complicated resistance mechanisms and limited treatment options. XDR-PA has demonstrated high resistance rate to new antibiotic ceftazidime-avibactam (CZA). Therefore, this study was conducted to describe the resistance mechanisms, molecular epidemiology, and type III secretion system (T3SS) of XDR-PA, as well as to evaluate the synergistic antibacterial activity of CZA combined with aztreonam (ATM) against XDR-PA via <i>in vitro</i> experiments, aiming at providing insights for the prevention, control and treatment strategies of XDR-PA infections.</p><p><strong>Methods: </strong>The carbapenemase resistance genes (VIM, IMP, NDM, KPC, GES, OXA-40) and T3SS virulence genes of XDR-PA isolates were identified using polymerase chain reaction (PCR) and sequencing. The expression levels of efflux pump systems (<i>mexA and mexC</i>), <i>oprD2</i> porin and <i>ampC</i> were detected by the real-time fluorescent quantitative PCR (qPCR). The homology analysis of XDR-PA isolates was performed using multilocus sequence typing (MLST). Combined antimicrobial susceptibility testing of CZA and ATM were performed for XDR-PA isolates through <i>in vitro</i> experiments.</p><p><strong>Results: </strong>A total of 32 XDR-PA strains were isolated from clinical specimens from a tertiary teaching hospital in Southwest China between October 2022 to October 2023. Among the carbapenemase detected, metallo-β-lactamase (MBL) NDM-1 and VIM-2 were detected in 26 strains (81.25%, 26/32) and 1 strain (3.13%, 1/32) respectively. The efflux pump <i>mexA</i> had a higher expression in the XDR-PA group than that in the sensitive-PA (S-PA) group (<i>P</i> = 0.015). The T3SS virulence genes carried by XDR-PA strains mainly were <i>exoY+/exoT+/exoU+/exoS-</i> (87.50%, 28/32). The 32 XDR-PA isolates belonged to 8 different ST types, mainly including ST1971 and ST308, and the predominant ST type was ST1971 (71.88%, 23/32), with carrying both NDM-1 and <i>exoY+/exoT+/exoU+/exoS-</i>. Combined antimicrobial susceptibility testing revealed that among the 27 CZA-resistant XDR-PA strains, CZA and ATM combination showed a synergistic effect on 21 CZA-resistant XDR-PA strains (77.78%, 21/27), of which 20 strains carrying both MBL (95.24%, 20/21) and <i>exoY+/exoT+/exoU+/exoS-</i>.</p><p><strong>Conclusion: </strong>The underlying resistance mechanisms of XDR-PA isolates involve the overexpression of efflux pump <i>mexA</i> and the existence of MBL. In addition, ST1971 was the predominant ST type in our study, with carrying both NDM-1 and <i>exoY+/exoT+/exoU+/exoS-</i>. Furthermore, combined antimicrobial susceptibility testing suggested that CZA and ATM combination has potential against MBL-producing <i>exoY+/exoT+/exoU+/exoS-</i> XDR-PA. These findings may provide clues for the prevention, control and treatment strategies of","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1737414"},"PeriodicalIF":4.8,"publicationDate":"2026-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12982442/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147462878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-27eCollection Date: 2026-01-01DOI: 10.3389/fcimb.2026.1760036
Jie Cao, Shike Long, Huan Liu, Ribin Liao, Fu An Chen, Xiyou Li, Lifeng Xu, Ying Liu
Background: Early assessment of acute pancreatitis (AP) severity is critical. We therefore built a web-based calculator that instantly estimates the probability that a patient admitted with AP will progress to the severe form.
Methods: Clinical records for patients who were diagnosed as AP at the Second Affiliated Hospital of Guilin Medical University between the start of 2016 and May 2025 were retrospectively examined. The dataset was randomly divided into training set (70%) and test set (30%). For the traditional machine learning models, we employed 5-fold cross-validation combined with random search for hyperparameter optimization during training. Feature selection was performed using Random Forest (RF) and the Least Absolute Shrinkage and Selection Operator (LASSO) methods. Model construction included Logistic Regression (LR), Decision Tree (DT), Naive Bayes (NB), Support Vector Machine (SVM), Multi-Layer Perceptron (MLP), Light Gradient Boosting Machine (LightGBM), Extreme Gradient Boosting (XGBoost), Artificial Neural Network (ANN), Convolutional Neural Network (CNN), and Long Short-Term Memory Network (LSTM). The area under the receiver operating characteristic curve (AUC), among other metrics, served to evaluate model efficacy. SHapley Additive exPlanations (SHAP) and Partial Dependency Plots (PDP) were employed to explain model predictions, and a clinical application risk prediction platform was further developed.
Results: 1289 patients with AP were included, with 11 variables screened to develop 10 models. Among these, the LightGBM demonstrated the highest predictive accuracy on training and test sets, with AUC (95% CI) values of 0.9726 (0.9626-0.9818) and 0.9301 (0.9113-0.9481), respectively. SHAP and PDP analyses identified Ca, WBC, α-HBDH, and Glu as key predictive features for severe acute pancreatitis (SAP). Calcium levels exerted a negative influence on SAP prediction, whereas WBC, α-HBDH, and Glu exerted positive influences, exhibiting positive synergistic effects among these three variables.
Conclusion: Our study highlights the substantial predictive potential of Ca, WBC, α-HBDH, and Glu for SAP. We have built a predictive online platform for clinical use, enabling healthcare professionals to rapidly and effectively assess SAP risk, thereby facilitating timely intervention and treatment.
{"title":"Predicting the acute pancreatitis severity with multi-machine learning models: constructing an online prediction platform.","authors":"Jie Cao, Shike Long, Huan Liu, Ribin Liao, Fu An Chen, Xiyou Li, Lifeng Xu, Ying Liu","doi":"10.3389/fcimb.2026.1760036","DOIUrl":"10.3389/fcimb.2026.1760036","url":null,"abstract":"<p><strong>Background: </strong>Early assessment of acute pancreatitis (AP) severity is critical. We therefore built a web-based calculator that instantly estimates the probability that a patient admitted with AP will progress to the severe form.</p><p><strong>Methods: </strong>Clinical records for patients who were diagnosed as AP at the Second Affiliated Hospital of Guilin Medical University between the start of 2016 and May 2025 were retrospectively examined. The dataset was randomly divided into training set (70%) and test set (30%). For the traditional machine learning models, we employed 5-fold cross-validation combined with random search for hyperparameter optimization during training. Feature selection was performed using Random Forest (RF) and the Least Absolute Shrinkage and Selection Operator (LASSO) methods. Model construction included Logistic Regression (LR), Decision Tree (DT), Naive Bayes (NB), Support Vector Machine (SVM), Multi-Layer Perceptron (MLP), Light Gradient Boosting Machine (LightGBM), Extreme Gradient Boosting (XGBoost), Artificial Neural Network (ANN), Convolutional Neural Network (CNN), and Long Short-Term Memory Network (LSTM). The area under the receiver operating characteristic curve (AUC), among other metrics, served to evaluate model efficacy. SHapley Additive exPlanations (SHAP) and Partial Dependency Plots (PDP) were employed to explain model predictions, and a clinical application risk prediction platform was further developed.</p><p><strong>Results: </strong>1289 patients with AP were included, with 11 variables screened to develop 10 models. Among these, the LightGBM demonstrated the highest predictive accuracy on training and test sets, with AUC (95% CI) values of 0.9726 (0.9626-0.9818) and 0.9301 (0.9113-0.9481), respectively. SHAP and PDP analyses identified Ca, WBC, α-HBDH, and Glu as key predictive features for severe acute pancreatitis (SAP). Calcium levels exerted a negative influence on SAP prediction, whereas WBC, α-HBDH, and Glu exerted positive influences, exhibiting positive synergistic effects among these three variables.</p><p><strong>Conclusion: </strong>Our study highlights the substantial predictive potential of Ca, WBC, α-HBDH, and Glu for SAP. We have built a predictive online platform for clinical use, enabling healthcare professionals to rapidly and effectively assess SAP risk, thereby facilitating timely intervention and treatment.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1760036"},"PeriodicalIF":4.8,"publicationDate":"2026-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12982339/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147462888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-27eCollection Date: 2026-01-01DOI: 10.3389/fcimb.2026.1711371
Min Xue, Xiaoling Wei, Bing Wang, Miao Liu, Yun Zhang, Xiang Ma
Objective: To analyze the clinical differences between pertussis and/or Mycoplasma pneumoniae (MP) infections in children and provide insights for clinical differential diagnosis.
Methods: We retrospectively reviewed children with respiratory symptoms who attended Shandong University Children's Hospital (Jinan, China) from 2019 to 2024 and underwent simultaneous testing for pertussis and MP. Patients were categorized as pertussis-only, MP-only, or dual-positive, and differences in demographics, seasonality, manifestations, hematologic indices, and co-detected pathogens were analyzed.
Results: A total of 7184 children were included: 2,982 pertussis-only, 3,166 MP-only, and 1,036 dual-positive. Significant differences were observed in sex (χ² = 30.964), age (χ² = 393.010), and season (χ² = 436.070) (all p < 0.001). Pertussis-only cases were more common in boys, during spring and winter, and in patients aged 6 years to <12 years. MP-only cases clustered in ages 2 to <6 and 6 to <12 years, with peaks in summer and autumn. Dual-positive cases were slightly more frequent in girls, clustered in the 6 to <12-year-old group, and occurred more often in spring and summer. Fever (χ² = 442.36, p < 0.001) was more frequent in the MP-only and dual-positive groups, whereas gastrointestinal symptoms (χ² = 30.00, p < 0.001), cyanosis (χ² = 12.91, p = 0.002), spasmodic cough (χ² = 212.07, p < 0.001), and cockcrow-like echo (χ² = 77.38, p < 0.001) were more common in the pertussis-only group. Lung crackles (χ² = 52.44, p < 0.001) and multilobar involvement (χ² = 28.08, p < 0.001) were predominantly observed in the MP-only group. The duration of cough before diagnosis was shorter in the MP-only group than in both the pertussis-only and dual-positive groups (H = 371.49, p < 0.001). Lymphocyte counts (H = 178.03) were the highest in the pertussis-only group, and neutrophil counts (H = 119.45) and C-reactive protein (H = 369.80) were the highest in the MP-only group (all p<0.001). Among the 7184 children, 1,224 (15.65%) had codetection of other pathogens, with human rhinovirus, Haemophilus influenzae, and Streptococcus pneumoniae most common. The MP-only group was more often accompanied with influenza A/B (χ² = 16.688, p < 0.001) and Legionella pneumophila (χ² = 12.715, p = 0.002); pertussis-only, Streptococcus pneumoniae (χ² = 11.872, p = 0.003); dual-positive, Klebsiella pneumoniae (χ² = 7.284, p = 0.009).
Conclusion: Pertussis and MP infections in children show distinct demographic, seasonal, clinical, and laboratory patterns. Recognition of these epidemiologic and clinical signatures supports early differentiation at the bedside and the use of multiplex PCR combined with specific laboratory markers to enable more targeted clinical management.
{"title":"Clinical characteristics analysis of pertussis and Mycoplasma pneumoniae infection in children.","authors":"Min Xue, Xiaoling Wei, Bing Wang, Miao Liu, Yun Zhang, Xiang Ma","doi":"10.3389/fcimb.2026.1711371","DOIUrl":"10.3389/fcimb.2026.1711371","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the clinical differences between pertussis and/or <i>Mycoplasma pneumoniae</i> (MP) infections in children and provide insights for clinical differential diagnosis.</p><p><strong>Methods: </strong>We retrospectively reviewed children with respiratory symptoms who attended Shandong University Children's Hospital (Jinan, China) from 2019 to 2024 and underwent simultaneous testing for pertussis and MP. Patients were categorized as pertussis-only, MP-only, or dual-positive, and differences in demographics, seasonality, manifestations, hematologic indices, and co-detected pathogens were analyzed.</p><p><strong>Results: </strong>A total of 7184 children were included: 2,982 pertussis-only, 3,166 MP-only, and 1,036 dual-positive. Significant differences were observed in sex (χ² = 30.964), age (χ² = 393.010), and season (χ² = 436.070) (all <i>p</i> < 0.001). Pertussis-only cases were more common in boys, during spring and winter, and in patients aged 6 years to <12 years. MP-only cases clustered in ages 2 to <6 and 6 to <12 years, with peaks in summer and autumn. Dual-positive cases were slightly more frequent in girls, clustered in the 6 to <12-year-old group, and occurred more often in spring and summer. Fever (χ² = 442.36, <i>p</i> < 0.001) was more frequent in the MP-only and dual-positive groups, whereas gastrointestinal symptoms (χ² = 30.00, <i>p</i> < 0.001), cyanosis (χ² = 12.91, <i>p</i> = 0.002), spasmodic cough (χ² = 212.07, <i>p</i> < 0.001), and cockcrow-like echo (χ² = 77.38, <i>p</i> < 0.001) were more common in the pertussis-only group. Lung crackles (χ² = 52.44, <i>p</i> < 0.001) and multilobar involvement (χ² = 28.08, <i>p</i> < 0.001) were predominantly observed in the MP-only group. The duration of cough before diagnosis was shorter in the MP-only group than in both the pertussis-only and dual-positive groups (H = 371.49, <i>p</i> < 0.001). Lymphocyte counts (H = 178.03) were the highest in the pertussis-only group, and neutrophil counts (H = 119.45) and C-reactive protein (H = 369.80) were the highest in the MP-only group (all p<0.001). Among the 7184 children, 1,224 (15.65%) had codetection of other pathogens, with human rhinovirus, <i>Haemophilus influenzae</i>, and <i>Streptococcus pneumoniae</i> most common. The MP-only group was more often accompanied with influenza A/B (χ² = 16.688, <i>p</i> < 0.001) and <i>Legionella pneumophila</i> (χ² = 12.715, <i>p</i> = 0.002); pertussis-only, <i>Streptococcus pneumoniae</i> (χ² = 11.872, <i>p</i> = 0.003); dual-positive, <i>Klebsiella pneumoniae</i> (χ² = 7.284, <i>p</i> = 0.009).</p><p><strong>Conclusion: </strong>Pertussis and MP infections in children show distinct demographic, seasonal, clinical, and laboratory patterns. Recognition of these epidemiologic and clinical signatures supports early differentiation at the bedside and the use of multiplex PCR combined with specific laboratory markers to enable more targeted clinical management.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1711371"},"PeriodicalIF":4.8,"publicationDate":"2026-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12982395/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147462814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-27eCollection Date: 2026-01-01DOI: 10.3389/fcimb.2026.1775865
Xiaodi Chen, Haiyan Zhou, Ruotong Li, Rongguo Li, Peng Liu
Background: As the principal cause of cervical cancer, human papillomavirus (HPV) infection is linked to vaginal infections such as bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), aerobic vaginitis (AV), and Trichomonas vaginalis (TV); however, the exact relationship remains controversial.
Methods: In this study, we performed a cross-sectional analysis of 10,104 women in Jinan, China, to establish a detailed association between HPV and vaginal infections.
Results: Our analysis showed that the HPV infection rate in Jinan was 21.84% of which the high-risk HPV (HR-HPV) infection rate was 84.32%. Although HR-HPV, low-risk HPV, BV, VVC, and TV prevalence rates across seasons were not statistically significant, we discerned significance for AV. In addition, while there was no difference between the prevalence of HPV and VVC, women with BV, AV, TV, or any vaginal infection manifested a higher risk of HPV infection. As for HR-HPV, our results showed statistically significant differences in HR-HPV infection rates between patients with BV, AV, TV, or any type of vaginal infection and the control group; however, VVC cases and cases without VVC did not differ. Furthermore, our correlation analysis among different HR-HPV genotypes and vaginal infections revealed an elevated incidence of BV in individuals with HPV45, HPV51, HPV52, HPV58, HPV66, and HPV68. AV exhibited an elevated infection rate in women with HPV16, HPV33, and HPV68; while TV demonstrated an increased infection risk in women with HPV52.
Conclusion: We hereby explored the complex relationship between HPV infection and vaginal infections and provided information on early-detection, preventive, and therapeutic strategies.
{"title":"Clinical epidemiology and associations between HPV infection and vaginal infections in Jinan, China: a cross-sectional analysis.","authors":"Xiaodi Chen, Haiyan Zhou, Ruotong Li, Rongguo Li, Peng Liu","doi":"10.3389/fcimb.2026.1775865","DOIUrl":"10.3389/fcimb.2026.1775865","url":null,"abstract":"<p><strong>Background: </strong>As the principal cause of cervical cancer, human papillomavirus (HPV) infection is linked to vaginal infections such as bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), aerobic vaginitis (AV), and <i>Trichomonas vaginalis</i> (TV); however, the exact relationship remains controversial.</p><p><strong>Methods: </strong>In this study, we performed a cross-sectional analysis of 10,104 women in Jinan, China, to establish a detailed association between HPV and vaginal infections.</p><p><strong>Results: </strong>Our analysis showed that the HPV infection rate in Jinan was 21.84% of which the high-risk HPV (HR-HPV) infection rate was 84.32%. Although HR-HPV, low-risk HPV, BV, VVC, and TV prevalence rates across seasons were not statistically significant, we discerned significance for AV. In addition, while there was no difference between the prevalence of HPV and VVC, women with BV, AV, TV, or any vaginal infection manifested a higher risk of HPV infection. As for HR-HPV, our results showed statistically significant differences in HR-HPV infection rates between patients with BV, AV, TV, or any type of vaginal infection and the control group; however, VVC cases and cases without VVC did not differ. Furthermore, our correlation analysis among different HR-HPV genotypes and vaginal infections revealed an elevated incidence of BV in individuals with HPV45, HPV51, HPV52, HPV58, HPV66, and HPV68. AV exhibited an elevated infection rate in women with HPV16, HPV33, and HPV68; while TV demonstrated an increased infection risk in women with HPV52.</p><p><strong>Conclusion: </strong>We hereby explored the complex relationship between HPV infection and vaginal infections and provided information on early-detection, preventive, and therapeutic strategies.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1775865"},"PeriodicalIF":4.8,"publicationDate":"2026-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12982392/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147462855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-27eCollection Date: 2026-01-01DOI: 10.3389/fcimb.2026.1806628
Piyush Baindara, Akil Akhtar
{"title":"Editorial: Viral pathogenesis and host defense: understanding the missing links to combat disease.","authors":"Piyush Baindara, Akil Akhtar","doi":"10.3389/fcimb.2026.1806628","DOIUrl":"https://doi.org/10.3389/fcimb.2026.1806628","url":null,"abstract":"","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1806628"},"PeriodicalIF":4.8,"publicationDate":"2026-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12982176/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147462890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Ceftazidime-avibactam represents a crucial therapeutic option for managing infections attributable to carbapenem-resistant P. aeruginosa. Nonetheless, the emergence of resistance to ceftazidime-avibactam in P. aeruginosa presents a significant challenge for clinical anti-infective therapy. This study primarily elucidates the mechanisms by which P. aeruginosa transitions from drug sensitivity to resistance during ceftazidime-avibactam treatment, ultimately resulting in therapeutic failure.
Methods: The susceptibility testing was performed using the broth microdilution method, conjugation experiment was performed via the filter mating method, the genetic surroundings of blaKPC-249 and comparison of plasmids structures was performed using short/long-read genome sequencing and analysis method, the resistance of transconjugant carried the blaKPC-249 to ceftazidime-avibactam was performed via molecular cloning method.
Results: For P. aeruginosa isolates from a patient, the minimum inhibitory concentrations (MICs) of ceftazidime-avibactam (CAZ-AVI) were determined as follows: isolates from sputum and bronchoalveolar lavage fluid both exhibited an MIC of 2 mg/L without blaKPC. In comparison, the blood-isolated strain P. aeruginosa PAE045 showed a significantly elevated MIC of >128 mg/L against CAZ-AVI. Plasmid conjugation experiments results demonstrated that the plasmid harboring the blaKPC-249 gene could be successfully transferred to the recipient strain PAO1 rifR (rifampicin-resistant P. aeruginosa PAO1). Third-generation sequencing results revealed that the blaKPC-249 gene was located on a plasmid with an approximate size of 37 kb. Compared with the wild-type e blaKPC-2 gene, the blaKPC-249 gene had two additional amino acid residues in its encoded protein: threonine (Thr, T) at position 182 and serine (Ser, S) at position 183. Furthermore, the upstream and downstream regions of the blaKPC-249 gene were flanked by the insertion sequences ISKpn6 and ISKpn27, respectively.
Discussion: These mobile genetic elements may play a role in the capture and dissemination of the blaKPC-249 gene. The blaKPC-249 gene is identified as a novel mutant variant of the blaKPC gene family, which mediates the resistance of P. aeruginosa to the antimicrobial agent ceftazidime-avibactam.
{"title":"The <i>bla<sub>KPC-249</sub></i> -mediated mechanism drives the transition of ST463 <i>Pseudomonas aeruginosa</i> from Ceftazidime-Avibactam sensitivity to resistance during clinical treatment.","authors":"Xiaosi Li, Yan Feng, Xiaoyan Wu, Heping Shen, Shumi Shang, Wenting Tang, Fupin Hu, Huijun Liang","doi":"10.3389/fcimb.2026.1744386","DOIUrl":"10.3389/fcimb.2026.1744386","url":null,"abstract":"<p><strong>Introduction: </strong>Ceftazidime-avibactam represents a crucial therapeutic option for managing infections attributable to carbapenem-resistant <i>P. aeruginosa</i>. Nonetheless, the emergence of resistance to ceftazidime-avibactam in <i>P. aeruginosa</i> presents a significant challenge for clinical anti-infective therapy. This study primarily elucidates the mechanisms by which <i>P. aeruginosa</i> transitions from drug sensitivity to resistance during ceftazidime-avibactam treatment, ultimately resulting in therapeutic failure.</p><p><strong>Methods: </strong>The susceptibility testing was performed using the broth microdilution method, conjugation experiment was performed via the filter mating method, the genetic surroundings of <i>bla</i> <sub>KPC-249</sub> and comparison of plasmids structures was performed using short/long-read genome sequencing and analysis method, the resistance of transconjugant carried the <i>bla</i> <sub>KPC-249</sub> to ceftazidime-avibactam was performed via molecular cloning method.</p><p><strong>Results: </strong>For <i>P. aeruginosa</i> isolates from a patient, the minimum inhibitory concentrations (MICs) of ceftazidime-avibactam (CAZ-AVI) were determined as follows: isolates from sputum and bronchoalveolar lavage fluid both exhibited an MIC of 2 mg/L without blaKPC. In comparison, the blood-isolated strain P. aeruginosa PAE045 showed a significantly elevated MIC of >128 mg/L against CAZ-AVI. Plasmid conjugation experiments results demonstrated that the plasmid harboring the <i>bla</i> <sub>KPC-249</sub> gene could be successfully transferred to the recipient strain PAO1 <i><sup>rifR</sup></i> (rifampicin-resistant <i>P. aeruginosa</i> PAO1). Third-generation sequencing results revealed that the <i>bla</i> <sub>KPC-249</sub> gene was located on a plasmid with an approximate size of 37 kb. Compared with the wild-type e <i>bla</i> <sub>KPC-2</sub> gene, the <i>bla</i> <sub>KPC-249</sub> gene had two additional amino acid residues in its encoded protein: threonine (Thr, T) at position 182 and serine (Ser, S) at position 183. Furthermore, the upstream and downstream regions of the <i>bla</i> <sub>KPC-249</sub> gene were flanked by the insertion sequences ISK<i>pn6</i> and ISK<i>pn27</i>, respectively.</p><p><strong>Discussion: </strong>These mobile genetic elements may play a role in the capture and dissemination of the <i>bla</i> <sub>KPC-249</sub> gene. The <i>bla</i> <sub>KPC-249</sub> gene is identified as a novel mutant variant of the <i>bla</i> <sub>KPC</sub> gene family, which mediates the resistance of <i>P. aeruginosa</i> to the antimicrobial agent ceftazidime-avibactam.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1744386"},"PeriodicalIF":4.8,"publicationDate":"2026-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12982449/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147462818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-27eCollection Date: 2026-01-01DOI: 10.3389/fcimb.2026.1749151
Abhishek K Singh, Madina Baglanova, Eylin Topfstedt, Kristin Surmann, Silva Holtfreter, Leif Steil, Uwe Völker, Michael Lammers, Barbara M Bröker, Karsten Becker, Clemens Cammann, Ulrike Seifert
Background: Ubiquitination is a posttranslational modification that affects protein function, stability, and localization and is thereby balancing protein homeostasis. During infection, ubiquitination is crucial in regulating host cell signaling pathways in pathogen recognition, clearance and mounting an efficient immune response. S. aureus is an opportunistic pathogen that is able to invade and multiply within both phagocytic and non-phagocytic mammalian cells depending on virulence factor expression of the respective S. aureus strain. Selective autophagy serves as a host defense mechanism to combat intracellular bacterial persistence by targeting and degrading intracellular pathogens. However, S. aureus can subvert autophagosomal degradation and exploit these organelles for intracellular replication.
Results: We examined the role of the E3 ligase S-phase kinase-associated protein 2 (SKP2), a component of the SKP1-Cullin1-F-box (SCF) - complex, during S. aureus infection in alveolar epithelial and in macrophage-like cells. Upon S. aureus infection, we demonstrate increased SKP2 abundance through acetylation-induced stabilization and translocation into the cytoplasm. Cytoplasmic SKP2 modulated autophagy induction. By downregulation of SKP2, the level of the autophagy marker LC3-II was elevated which was accompanied by increased survival of intracellular S. aureus. Conversely, SKP2 overexpression in host cells reduced LC3-II levels followed by reduced intracellular bacteria.
Conclusion: These findings underscore that SKP2 is an important regulator of autophagosome formation, preventing excessive autophagy from being exploited by S. aureus. In conclusion, our findings reveal novel molecular mechanisms involved in the interaction between host cells and S. aureus providing potential approaches for targeted therapeutic intervention.
{"title":"E3 ubiquitin ligase SKP2 limits autophagosome formation during <i>Staphylococcus aureus</i> infection.","authors":"Abhishek K Singh, Madina Baglanova, Eylin Topfstedt, Kristin Surmann, Silva Holtfreter, Leif Steil, Uwe Völker, Michael Lammers, Barbara M Bröker, Karsten Becker, Clemens Cammann, Ulrike Seifert","doi":"10.3389/fcimb.2026.1749151","DOIUrl":"10.3389/fcimb.2026.1749151","url":null,"abstract":"<p><strong>Background: </strong>Ubiquitination is a posttranslational modification that affects protein function, stability, and localization and is thereby balancing protein homeostasis. During infection, ubiquitination is crucial in regulating host cell signaling pathways in pathogen recognition, clearance and mounting an efficient immune response. <i>S. aureus</i> is an opportunistic pathogen that is able to invade and multiply within both phagocytic and non-phagocytic mammalian cells depending on virulence factor expression of the respective <i>S. aureus</i> strain. Selective autophagy serves as a host defense mechanism to combat intracellular bacterial persistence by targeting and degrading intracellular pathogens. However, <i>S. aureus</i> can subvert autophagosomal degradation and exploit these organelles for intracellular replication.</p><p><strong>Results: </strong>We examined the role of the E3 ligase S-phase kinase-associated protein 2 (SKP2), a component of the SKP1-Cullin1-F-box (SCF) - complex, during <i>S. aureus</i> infection in alveolar epithelial and in macrophage-like cells. Upon <i>S. aureus</i> infection, we demonstrate increased SKP2 abundance through acetylation-induced stabilization and translocation into the cytoplasm. Cytoplasmic SKP2 modulated autophagy induction. By downregulation of SKP2, the level of the autophagy marker LC3-II was elevated which was accompanied by increased survival of intracellular <i>S. aureus</i>. Conversely, SKP2 overexpression in host cells reduced LC3-II levels followed by reduced intracellular bacteria.</p><p><strong>Conclusion: </strong>These findings underscore that SKP2 is an important regulator of autophagosome formation, preventing excessive autophagy from being exploited by <i>S. aureus</i>. In conclusion, our findings reveal novel molecular mechanisms involved in the interaction between host cells and <i>S. aureus</i> providing potential approaches for targeted therapeutic intervention.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1749151"},"PeriodicalIF":4.8,"publicationDate":"2026-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12982375/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147462836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Porcine reproductive and respiratory syndrome (PRRS) is a widely prevalent disease of reproductive failure of pregnant pigs and respiratory syndromes in pigs of different ages, especially in piglets. The etiological agents include PRRS virus (PRRSV) genotypes 1 (PRRSV-1) and PRRSV-2, whereas their clinical symptoms are similar and hard to differentiate. It is necessary to establish accurate and reliable methods for differential detection of PRRSV-1 and PRRSV-2.
Methods: Two pairs of specific primers and probes were designed basing on the PRRSV-1 and PRRSV-2 ORF6 gene. The reaction conditions and procedures of the duplex crystal digital PCR (cdPCR) were optimized. The specificity, sensitivity, and repeatability of the developed assay were evaluated. The application of the developed assay was assessed by testing 2,185 clinical tissue samples.
Results: The results indicated that the concentration of the templates and their Ct values had good linear relationship with R2 of 0.998. This method could specifically detect PRRSV-1 and PRRSV-2, without cross-reaction with other swine viruses. The limits of detection (LODs) of the assay were 4.507 copies/reaction and 5.607 copies/reaction for PRRSV-1 and PRRSV-2, respectively, which was approximately 30 times more sensitive than that of the duplex real-time quantitative PCR (qPCR). The repeatability test showed that the intra- and inter-assay coefficients of variation (CVs) were 0.74%-0.93% and 0.63%-1.62%, respectively. This method was validated by testing 2,185 clinical samples from Guangxi Province in South China, and the positivity rates of PRRSV-1 and PRRSV-2 were 2.20% (48/2,185) and 23.43% (512/2,185), respectively. The coincidence rates of the developed assay with the qPCR assay recommended by the World Organisation of Animal Health (WOAH) were 99.73% and 99.73%, respectively, while with the duplex qPCR developed in this study were 99.82% and 99.77%, respectively.
Conclusions: These results indicated that a rapid and accurate duplex cdPCR method with high sensitivity and excellent specificity had been successfully developed for the differential detection of PRRSV-1 and PRRSV-2.
{"title":"Development of a novel duplex crystal digital PCR for the detection of PRRSV-1 and PRRSV-2.","authors":"Yuwen Shi, Jiakang He, Kaichuang Shi, Yanwen Yin, Feng Long, Shuping Feng, Zuzhang Wei","doi":"10.3389/fcimb.2026.1701517","DOIUrl":"10.3389/fcimb.2026.1701517","url":null,"abstract":"<p><strong>Background: </strong>Porcine reproductive and respiratory syndrome (PRRS) is a widely prevalent disease of reproductive failure of pregnant pigs and respiratory syndromes in pigs of different ages, especially in piglets. The etiological agents include PRRS virus (PRRSV) genotypes 1 (PRRSV-1) and PRRSV-2, whereas their clinical symptoms are similar and hard to differentiate. It is necessary to establish accurate and reliable methods for differential detection of PRRSV-1 and PRRSV-2.</p><p><strong>Methods: </strong>Two pairs of specific primers and probes were designed basing on the PRRSV-1 and PRRSV-2 ORF6 gene. The reaction conditions and procedures of the duplex crystal digital PCR (cdPCR) were optimized. The specificity, sensitivity, and repeatability of the developed assay were evaluated. The application of the developed assay was assessed by testing 2,185 clinical tissue samples.</p><p><strong>Results: </strong>The results indicated that the concentration of the templates and their Ct values had good linear relationship with R<sup>2</sup> of 0.998. This method could specifically detect PRRSV-1 and PRRSV-2, without cross-reaction with other swine viruses. The limits of detection (LODs) of the assay were 4.507 copies/reaction and 5.607 copies/reaction for PRRSV-1 and PRRSV-2, respectively, which was approximately 30 times more sensitive than that of the duplex real-time quantitative PCR (qPCR). The repeatability test showed that the intra- and inter-assay coefficients of variation (CVs) were 0.74%-0.93% and 0.63%-1.62%, respectively. This method was validated by testing 2,185 clinical samples from Guangxi Province in South China, and the positivity rates of PRRSV-1 and PRRSV-2 were 2.20% (48/2,185) and 23.43% (512/2,185), respectively. The coincidence rates of the developed assay with the qPCR assay recommended by the World Organisation of Animal Health (WOAH) were 99.73% and 99.73%, respectively, while with the duplex qPCR developed in this study were 99.82% and 99.77%, respectively.</p><p><strong>Conclusions: </strong>These results indicated that a rapid and accurate duplex cdPCR method with high sensitivity and excellent specificity had been successfully developed for the differential detection of PRRSV-1 and PRRSV-2.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1701517"},"PeriodicalIF":4.8,"publicationDate":"2026-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12982388/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147462885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}